Brind.

The FDA authorized IceCure Medical's ProSense system for specific indications.

1 report, 1 independent Updated Jun 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA IceCure Medical

Keep exploring

The entities involved

FDA
- Amidst panel votes, Robert F. Kennedy Jr. seeks to overturn FDA restrictions regarding peptides, while critics question safety data.06:03
- Replimune Group, Inc. received accelerated approval for TUDRIQEV™ in advanced melanoma, while its stock price reflected quarterly EPS misses.05:01
IceCure Medical
Nothing else this week.

Related events

EyePoint Pharmaceuticals developed its LUCIA trial program in alignment with the FDA, with enrollment noted in Lugano.Jun 8
Arcutis Biotherapeutics submitted a supplemental New Drug Application (sNDA) to the FDA to expand the indication for its drug ZORYVE.Jun 7

Coverage

Newest first; wire copies grouped

Jun 18investorideas.com